Abstract
Exogenous human albumin administration has shown improved outcomes in patients requiring intravascular resuscitation (e.g., spontaneous bacterial peritonitis, and hepatorenal syndrome). However, its acute use in other conditions and liver disease-associated complications requiring fluid resuscitation is unclear. We applied machine learning (ML) techniques to electronic health records data from patients with anemia and gastrointestinal bleeding, alcoholic liver disease, hepatic failure, acute pancreatitis, and nephrotic syndrome, to identify subpopulations that may benefit from early albumin administration.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.